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REGULATING MOLECULAR RESPONSES IN MOUSE AND HUMAN SEPSISAdnan Aslan,* Matijs van Meurs,*† Jill Moser,*† Eliane R. Popa,†
Rianne M. Jongman,*†‡ Peter J. Zwiers,† Grietje Molema,† and Jan G. Zijlstra*
*Department of Critical Care, University Medical Center Groningen, University of Groningen, Groningen,
Netherlands; †Department of Pathology and Medical Biology, Medical Biology Section, University Medical
Center Groningen, University of Groningen, Groningen, Netherlands; and ‡Department of
Anaesthesiology, University Medical Center Groningen, University of Groningen, Groningen, Netherlands
Received 22 Oct 2016; first review completed 21 Nov 2016; accepted in final form 17 Jan 2017ABSTRACT—In patientswith sepsis-inducedmulti-organ dysfunction syndrome, diverging patterns of oedema formation and
loss of function in organs such as lung and kidney suggest that endothelial permeability-regulating molecular responses are
differentially regulated. This potential differential regulation has been insufficiently studied at the level of components of
adherens and tight junctions. We hypothesized that such a regulation by endothelial cells in sepsis takes place in an organ-
specific manner. We addressed our hypothesis by studying by quantitative real time polymerase chain reaction the expression
of a predefined subset of EC permeability-related molecules (occludin, claudin-5, PV-1, CD-31, endomucin, Angiopoietin-1,
Angiopoietin-2, Tie2, VEGFA, VEGFR1, VEGFR2, and VE-cadherin) in kidney and lung after systemic lipopolysacharide
injection in mice, and in kidneys of patients who died of sepsis. We showed that baseline endothelial expression of
permeability-related molecules differs in mouse kidney and lung. Moreover, we showed differential regulation of these
molecules after lipopolysacharide injection in the two mouse organs. In lung we found a decrease in expression levels of
molecules of the adherence and tight junctions complex and related signaling systems, compatible with increased
permeability. In contrast, in kidney we found expression patterns of these molecules compatible with decreased permeability.
Finally, we partially corroborated our findings inmouse kidney in human kidneys from septic patients. These findingsmay help
to understand the clinical difference in the extent of oedema formation in kidney and lung in sepsis-associated organ failure.
KEYWORDS—Cell–cell junctions, endothelium, human, kidney, LPS, lung, MODS, mouse, sepsis, vascular permeabilityINTRODUCTION
Sepsis poses a major morbidity and mortality burden since it
can result in multi-organ dysfunction syndrome (1). The precise
mechanisms leading to MODS are largely unknown (2).
Initially, circulating humeral and cellular components of the
immune and coagulation system were held responsible for the
development of MODS. However, more recent studies suggest
that the breakdown of the endothelial cell (EC) barrier, result-
ing in alterations in vascular permeability, oedema formation,
and, finally, loss of organ function, plays a crucial role in the
pathogenesis of MODS (3, 4).
Interestingly, oedema formation in, and loss of function of
different organs in patients with MODS does not follow a
uniform pattern. For example, the lung dysfunctions partially
due to oedema and flooding after loss of endothelial barrier
integrity and gap formation (5). On the other hand, oedema
formation in the failing kidney is limited. Acute kidney injury
(AKI) is marked by anuria, which could be interpreted as a result
of decreased permeability of the glomerular sieving membrane.
These observations suggest that differential responses of theCopyright © 2017 by the Shock Society. Unauthorize
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69endothelial barrier in lung and kidney might be responsible for
these diverging patterns of oedema formation.
Under physiological conditions, the endothelial barrier func-
tion is maintained by junctions between EC and with the basal
membrane. Vascular permeability, and thus the paracellular flow
of fluids, electrolytes, proteins, and cells through the endothelial
layer, ismainly controlled bymolecules of the adherens and tight
junctions (6–11), a subset of which is visualized in Figure 1A (8,
11–14). These EC junctions are dynamic structures that can be
regulated at transcriptional, translational, and post-translational
levels, resulting in permeability changes. For example, phos-
phorylation of adherens junctions molecules and their sub-
sequent internalisation and degradation are key regulators of
endothelial permeability (4, 7, 15). In MODS, disruption of EC
junctions has been, indeed, associated with altered vascular
permeability (7, 16, 17). In trauma patients there is a severity-
related increase in plasma of junctional molecules (18).
It is currently unclear whether diverging outcomes in oedema
formation and organ failure in MODS is attributable to differ-
ential, organ-specific regulation of endothelial barrier mol-
ecules. In this study, we hypothesized that in sepsis the
molecular systems that control endothelial barrier function
are differentially regulated in an organ-specific manner. To
test our hypothesis, we studied the expression of mRNA of a
predefined set of EC permeability-related proteins in kidney
and lung after systemic exposure of lipopolysacharide (LPS) in
mice. LPS in mice does not resemble human sepsis but some
responses seen in sepsis can be elicited in this model (19–21).
Expression of these molecules was furthermore investigated in
post-mortem kidney biopsies of septic AKI patients. Thed reproduction of this article is prohibited.
FIG. 1. Regulation of vascular permeability by microvascular endothelial cells. Molecules involved in vascular permeability and studied in the current
study are shown schematically. A, In critically ill patients, pulmonary edema (chest X ray upper left) with increased pulmonary vascular leakage, and anuria (urine
collection bag without urine, upper right) can be observed at the same time. Vascular endothelial cells (EC) cover all blood vessels in close association with
supporting pericytes and play a vital role in regulating vascular leakage in health and disease, for an example in sepsis. Vascular permeability control is located in
tight junctions (Claudin-5 and Occludin) and adherence junctions (VE-cadherin). Both the Ang/Tie2 (angiopoietin/Tie2 system) and the VEGFA/VEGFR1-
VEGFR2 (Vascular Endothelial Growth Factor A and its receptors VEGFreceptor 1, VEGFR1, also known as Flt-1) and VEGFreceptor 2 (VEGFR2, also known as
KDR) regulate vascular leakage. Angiopoietin1 (Ang1) is constitutively produced by pericytes and promotes EC integrity. During stress, endothelial cells release
Angiopietin2 (Ang2) from intracellular Weibel Palade Bodies (WPB). Ang2 is a competitive Tie2 antagonist and promotes vascular leakage. PV1 protein
(plasmalemmal vesicle associated protein-1) is required for endothelial diaphragm formation. CD31, also known as platelet endothelial cell adhesion molecule 1
(PECAM-1), and endomucin are involved in leukocyte trafficking. B, Basal gene expression levels of the molecules that are investigated in this study in healthy
mouse kidney (white) and lungs (gray) normalized to the highest expressed gene (VEGFA in kidney and VE-cadherin in lungs).
70 SHOCK VOL. 48, No. 1 ASLAN ET AL.obtained knowledge may aid in rational development of thera-
pies that target vascular permeability in MODS.MATERIALS AND METHODS
Animals
Eight- to 12-week-old C57Bl/6 male mice (20–30 g) were obtained from
Harlan (Horst, The Netherlands). Micewere maintained onmouse chow and tap
water ad libitum in a temperature-controlled chamber at 24 8C with a 12-h light/
dark cycle. All procedures were approved by the local committee for care and
use of laboratory animals and were performed according to governmental and
international guidelines on animal experimentation (20, 21).
Mouse LPS model
To induce endotoxemia, mice were injected intraperitoneally (i.p.) with LPS
(Escherichia coli, serotype 026:B6l; Sigma, St. Louis,Mo) at 0.5mg/kg (1,500EU/
g) body weight. After 4, 8, or 24h, blood was withdrawn via aortic puncture under
isoflurane anesthesia, and the kidneys and lungs were excised, snap-frozen in liquid
nitrogen, and stored at 80 8C until analysis. Untreated control mice were used as
controls. All groups contained five mice and were previously reported.
Human kidney tissue
Kidney biopsies were obtained directly post-mortem from 19 patients aged
18 years or older, who died of sepsis; a subset of these biopsies was previouslyCopyright © 2017 by the Shock Society. Unauthorreported (22). Exclusion criteria were pre-existing chronic kidney disease,
active auto-immune disorder with renal involvement, and immune-suppressive
treatment. Kidneys from 12 patients diagnosed with kidney cancer who under-
went a total nephrectomy of the diseased kidney, served as controls. Family was
given oral and written information about the post-mortem study. Oral and
written, signed consent was obtained from the family. This study was waived by
the Medical Ethical Committee (METc 2011/372).
Gene expression analysis by quantitative RT-PCR
RNA was isolated from cryosections of mouse kidney and lung, and from
cryosections of human kidney, using the RNeasy Mini Plus Kit (Qiagen, Venlo,
The Netherlands), according to the manufacturer’s instructions, and as previously
described (20). cDNAwas synthesized using Superscript III Reverse Transcrip-
tase (Invitrogen, Breda, The Netherlands) and random hexamer primers (Prom-
ega, Leiden, The Netherlands). Mouse and human-specific Assay-on-Demand
primers (Applied Biosystems, Nieuwekerk a/d IJssel, The Netherlands) were
selected to amplify VEGFA, VEGFR1, VEGFR2, Ang1, Ang2, Tie-2, PV-1, VE-
Cadherin, claudin-5, occludin, CD31, and endomucin (Table 1). Glyceraldehyde-
3-phosphate dehydrogenase (GAPDH)was used as housekeeping gene.Duplicate
real-time PCR analyses were performed for each sample and the obtained
threshold cycle (CT) values were averaged. Gene expression was normalized
to the averaged expression of the housekeeping gene, yielding the DCT value.
Relative gene expression levels were calculated by 2DCT.
Western blot
mRNA expression levels of VE-cadherin were determined at protein level by
Western blot. Briefly, mouse tissue homogenates were boiled for 5 min,ized reproduction of this article is prohibited.
TABLE 1. Mouse and human assay-on-demand primers
Gene Mouse assay ID Human assay ID













SHOCK JULY 2017 CELL JUNCTION MOLECULES IN SEPSIS 71separated by SDS-PAGE on a 7.5% polyacrylamide gel, and blotted onto
nitrocellulose membrane (Biorad, Veenendaal, The Netherlands). The mem-
brane was blocked for 1 h in 5% (w/v) dry milk in Tris-buffered saline
containing 0.1% (v/v) Tween-20 (TBS-T) and probed overnight with rat
antibody to VE-cadherin in 2% (w/v) dry milk in TBS-T0.1%, and 1 h with
mouse anti Actin (MAB1501, Merck Millipore, Darmstadt, Germany) diluted
in 5% (w/v) BSA in TBS-T 0.1%. The membranes were subsequently washed
with TBS-T0.1% and incubated with horseradish peroxidase-labeled anti-rat
IgG and anti-mouse IgG (SouthernBiotech, Birmingham, Ala). After washing
the membranes extensively in TBS-T0.1%, antibody binding was detected
using SuperSignal West Pico Chemiluminescent Substrate (Thermo Fisher
Scientific, Bleiswijk, The Netherlands). Loading of protein was normalized
by Actin. The blots were scanned and optical densities of the protein bands were
quantified by Quantity One software (Bio-Rad, Calif).
Statistical analyses
Statistical significance of differences was calculated using the Student t test
or ANOVA with post hoc comparison using Dunnet correction. Statistical
analyses were performed using GraphPad Prism software (GraphPad Prism
Software Inc, San Diego, Calif). Differences were considered to be significant
when P< 0.05.TABLE 2. Basal mRNA expression* of molecules under study in
murine kidney and lung
Gene Kidney† Lung†
Occludin 0.0041 (0.0003) 0.0660 (0.0270)
Claudin-5 0.0002 (0.00003) 0.1906 (0.1411)
VE-cadherin 0.0056 (0.0009) 1.2187 (0.6225)
PV-1 0.0055 (0.0010) 0.4771 (0.2179)
CD31 0.0052 (0.0006) 0.4502 (0.2184)
Endomucin 0.0107 (0.0020) 0.0540 (0.0253)
Ang1 0.0019 (0.0002) 0.0449 (0.0225)
Ang2 0.0006 (0.0001) 0.0061 (0.0035)
Tie2 0.0030 (0.0003) 0.1615 (0.0745)
VEGFA 0.0119 (0.0006) 0.5413 (0.2634)
VEGFR1 0.0053 (0.0025) 0.1193 (0.0544)
VEGFR2 0.0039 (0.0006) 0.165 (0.0771)
*mRNA expression levels were determined using quantitative RT-PCR
with GAPDH as reference gene.
†Data are presented as mean and SD of each group (n¼5animals/
group).RESULTS
Expression of endothelial permeability-regulating
molecules in LPS-injected mice
Organ expression of tight junctions molecules—Expression
levels of the tight junctions molecules occludin and claudin-5
were determined in kidneys and lungs of LPS-injected and
untreated (control) mice (Fig. 1B). In untreated mice, expression
of occludin was 10- to 20 times higher in lungs than in kidneys
(Table 2). In kidneys, LPS injection resulted in a slight increase
in occludin expression at 8 h and a subsequent decrease at 24 h.
In lungs, LPS injection led to a persistent decrease in occludin
expression at 4, 8, and 24 h (Fig. 2, A and B).
Expression of claudin-5 in untreated mice was 100 times
higher in lungs than in kidneys (Table 2). After LPS injection,
an increase in claudin-5 mRNA levels was observed at 8 h in
kidney. In lung there was a reduction of claudin-5 expression
only at 24 h (Fig. 2, C and D).
Organ expression of adherence junction molecule VE-cad-
herin—In untreated mice, mRNA expression of VE-Cadherin
was 200 times higher in lungs than in kidneys (Table 2). After
LPS injection, VE-cadherin expression was increased 3-fold at
4 and 8 h in kidney, and although decreasing at 24 h, was still
elevated at this latter time point compared to untreated mice. In
the lung, LPS injection resulted in a decrease in VE-cadherin
expression at 24 h (Fig. 2, E and F).Copyright © 2017 by the Shock Society. UnauthorizeAfter LPS injection, VE-cadherin protein expression in the
kidney did not differ from that in untreated mice, while in the
lung there was a temporary decrease with the nadir at 4 h
(Fig. 3, A and B).
Expression of mediators of diapedesis
and transcellular transport
Organ expression of transcellular transport molecule PV-
1—In untreated mice, expression of PV-1 was 50 times higher
in the lung than in the kidney (Table 2). In both kidney and lung,
PV-1 expression decreased at 4 and 8 h after LPS injection,
compared with untreated mice. An increase above control
levels was observed at 24 h in kidney, while in lung the levels
remained low (Fig. 2, H and I).
Organ expression of CD31—In untreated mice, CD31
expression was 100 times higher in the lung than in the kidney
(Table 2). In kidney, CD31 expression was reduced at 4 h after
LPS injection, and increased at 24 h compared with untreated
mice. In lung, CD31 expression decreased at 4 and 8 h after LPS
injection and returned to baseline levels at 24 h (Fig. 2, J and K).
Organ expression of endomucin—Endomucin expression in
untreated mice was three times higher in the lung than in the
kidney (Table 2). After LPS injection, endomucin expression
decreased at 4 and 8h in both kidney and lung.At 24h, endomucin
expression had reached baseline levels in the lung but were still
higher than in controls in the kidney (Fig. 2, L and M).
Expression of vascular stability-related
signaling molecules
Organ expression of molecules of the Angiopoietin/Tie2
system—In untreated mice, expression of Ang1 was 20 times
higher in lungs than in kidneys (Table 2). In kidney, decrease in
Ang1 expression was only observed at 8 h after LPS injection.
In lung, there was a significant decrease in Ang1 expression,
which persisted until 24 h (Fig. 4 A and B).
Expression of Ang2 was 500 times higher in lungs than in
kidneys of untreated mice (Table 2). After LPS injection there
was an increase in Ang2 expression at 4 and 8 h in both kidney
and lung, which returned to baseline at 24 h in both organs
(Fig. 4, C and D).d reproduction of this article is prohibited.
FIG. 2. Influence of LPS challenge on expression of occludin, claudin-5, VE-cadherin, PV-1, CD31, and endomucin in mouse kidney and lung.Mice
were i.p. injected with LPS at 0.5mg/kg (1,500EU/g) bodyweight and sacrificed 4, 8, and 24h later. Control mice were left untreated. mRNA expression of occludin
(A, B), claudin-5 (C, D), VE-cadherin (E, F), PV-1 (H, I), CD31 (J, K), and endomucin (L, M) in kidney (A, C, E, H, J, L) and lungs (B, D, F, I, K, M) was determined
using quantitative RT-PCR with GAPDH as housekeeping gene. Data are presented as meanSD (n¼5animals/group). Significance P<0.05.
72 SHOCK VOL. 48, No. 1 ASLAN ET AL.Since Ang1 is a Tie2 agonist leading to Tie2 phosphoryl-
ation, and Ang2 is a partial Tie2 antagonist during inflam-
mation (23), the Ang1/Ang2 ratio may be used to predict Tie2
phosphorylation in vivo. In untreated mice, the Ang1/Ang2
mRNA ratio was 3.9 in the kidney and 12.7 in the lung. After
LPS injection, the Ang1/Ang2 ratiowas reduced in both organs.
This decrease in the Ang1/Ang2 ratio was more pronounced in
lungs than in kidneys (not shown).Copyright © 2017 by the Shock Society. Unauthor
FIG. 3. Influence of LPS injection on VE-cadherin protein expression i
(1,500EU/g) bodyweight and sacrificed 4, 8, and 24h later. VE-cadherin protein wa
quantified in kidney (A) and lung (B). Data are presented as mean VE-cadherin/In untreated mice Tie2 expression was 50 times higher in the
lung than in the kidney (Table 2). Tie 2 expression decreased in
both organs at 4 and 8 h after LPS injection. At 24 h after LPS
injection, Tie2 expression was higher in kidney and lower in
lung than in their respective controls (Fig. 4, E and F).
Organ expression of VEGFA, and its receptors VEGFR1 and
VEGFR2—In untreated mice, VEGFA expression was 50 times
higher in the lung than in the kidney (Table 2). After LPSized reproduction of this article is prohibited.
n mouse kidney and lung. Mice were i.p. injected with LPS at 0.5mg/kg
s determined usingWestern blot and b-actin was used as a loading control and
b-actin ratioSD (n¼5animals/group). Significance P<0.05.
FIG. 4. Influence of LPS injection on mRNA expression of ligands and receptors of the angiopoietin/Tie2 system and the VEGFA/VEGF-receptor
system inmouse kidney and lung.Mice were i.p. injected with LPS at 0.5mg/kg (1,500EU/g) bodyweight and sacrificed at 4, 8, and 24h later. mRNA expression
of Ang1 (A, B), Ang2 (C, D), Tie2 (E, F), VEGFA (G, H), VEGFR1 (I, J), and VEGFR2 (K, L) in kidney (A, C, E, G, I, K) and lungs (B, D, F, H, J, L) was determined
using quantitative RT-PCR with GAPDH as housekeeping gene. Data are presented as meanSD (n¼5animals/group). Significance P<0.05.
SHOCK JULY 2017 CELL JUNCTION MOLECULES IN SEPSIS 73injection, VEGFA expression in kidney was increased at 4 h,
and decreased at 8 h. In lung, VEGFA expression was decreased
at 8 and 24 h (Fig. 4, G and H).
VEGFR1 expression in untreated mice was 20 times higher
in the lung than in the kidney (Table 2). LPS injection did not
affect expression of VEGFR1 in kidney, but led to its reduction
at 8 and 24 h in lung (Fig. 4, I and J).
VEGFR2 expression in untreated mice was 40 times higher
in the lung than in the kidney (Table 2). After LPS injection,
VEGFR2 expression in kidney was unaffected, while it was
reduced at all time points in lung (Fig. 4, K and L).
Expression of endothelial permeability regulating
molecules in kidney biopsies of patients who died
of sepsis
The biopsies were taken after dying with a mean time elapse
of 33 min. No distinct patterns of expression of the tight- and
adherence junctions molecules were present between kidneys
from septic patients and controls, since expression of occludin
and VE-cadherin did not differ between the two groups
(Fig. 5,A), while expression of Claudin-5 expression was
increased in kidneys from septic patients (Fig. 5B).
Expression of the mediators of diapedesis and transcellular
transport PV1 (Fig. 5D) and CD31 (Fig. 5E) was increased in
kidneys from septic patients, while endomucin expression was
decreased in this group (Fig. 5F).Copyright © 2017 by the Shock Society. UnauthorizeAs expected, Ang1 expression was decreased, whereas
expression of Ang2 was increased in kidneys from septic
patients (Fig. 5, G and H). No difference in expression of
the angiopoietin receptor Tie2 was present in kidneys from
from septic patients and controls (Fig. 5I).
Expression of VEGFAwas decreased in kidneys from septic
patients (Fig. 5J). Expression of VEGFR1 was similar between
the two groups (Fig. 5K), whereas expression of VEGFR2 was
lower in septic kidneys than in controls (Fig. 5L).DISCUSSION
MODS in critically ill patients is associated with changes in
microvascular integrity, with the clinical impression that lung
capillaries become leaky while renal capillaries become less
permeable. Here, we hypothesized that these organ-specific
differences in permeability are attributable to differential
regulation of molecular systems that control endothelial bar-
rier function. To address this hypothesis we studied the
expression of a predefined subset of EC permeability-related
molecules in lung and kidney after i.p. LPS injection in mice,
and in kidneys of patients who died of sepsis. We showed that
baseline expression of mRNA of these molecules differs
between mouse lung and kidney. Moreover, we showed differ-
ential regulation of these molecules after LPS injection in the
two mouse organs. Finally, we partially corroborated thed reproduction of this article is prohibited.
FIG. 5. mRNA expression levels of Occludin, Claudin-5, VE-Cadherin, PV-1, CD31, endomucin, Ang1, Ang2, Tie2, VEGFA, VEGFR1, VEGFR2 in
kidney of human septic patients and controls. mRNA expression of Occludin (A), Claudin-5 (B), PV1 (C), CD31 (D), Endomucin (E), VE-cadherin (F), Ang1
(G), Ang2 (H), Tie2 (I), VEGFA (J), VEGFR1 (K), VEGFR2 (L) was determined using quantitative RT-PCR with GAPDH as housekeeping gene in human kidney
biopsies of septic patients (n¼19) and controls (n¼12). Data are presented as meanSD. Significance P<0.05.
74 SHOCK VOL. 48, No. 1 ASLAN ET AL.findings in mouse kidney biopsies obtained in from septic
patients shortly after death.
The main molecular systems dictating vascular permeability
are the tight and adherens junctions. We assessed expression of
their flagship molecules occludin, claudin-5, and VE-cadherin.
Reduction of occludin and claudin-5 expression is associated
with breakdown of the endothelial barrier in the brain (24).
Moreover, disassembly of claudin-5 from tight junctions has
been shown to lead to increased vascular permeability (24, 25).
Similarly, downregulation of VE-cadherin causes an increase in
vascular permeability (14, 26). In our study, baseline expressionCopyright © 2017 by the Shock Society. Unauthorlevels of occludin, claudin-5, and VE-cadherin markedly dif-
fered between kidney and lung, with claudin-5 and VE-cad-
herin being highly expressed in lung, and occludin being highly
expressed in kidney.
Interestingly, lung responses to LPS were marked by reduced
expression of both tight junction molecules occludin and
claudin-5, and of the adherens junction molecule VE-cadherin,
albeit following different kinetics. These findings are in line
with the clinical hypothesis that lung oedemamay be associated
with a compromised endothelial barrier. Also in a mouse
model of trauma a decreased expression of junctional adhesionized reproduction of this article is prohibited.
SHOCK JULY 2017 CELL JUNCTION MOLECULES IN SEPSIS 75molecule-1 (JAM-1) protein also suggests a hampered endo-
thelial barrier (18). Conversely, kidney responses to LPS were
marked by a temporary increased expression of occludin,
claudin-5, and VE-cadherin at 8 h after LPS, corroborating
the notion that decreased permeability of renal microvascula-
ture may lead to anuria. Whether the absence of a correlation
between mRNA and protein expression levels of VE-cadherin
in both organs reflects a dichotomy betweenmRNA and protein
regulation per se, or a microvascular segment-specific response
that was masked by total organ analysis, needs to be further
investigated using more advanced techniques to quantify
protein and phospho-protein expression (6, 27).
Based on these findings on renal endothelial responses to
LPS in mice, we expected to find an increased expression of the
studied tight- and adherens junctions in human septic kidneys
as compared to healthy kidneys. The lack of such a differential
expression in kidneys of sepsis and control patients may be
partly attributable to the process of dying itself, and to technical
issues such as the post mortem time point of biopsy sampling,
which may both affect mRNA levels. But above all this may be
a reflection of the huge gap between a laboratory model and
clinic. Obviously, the time course of changes in these molecules
cannot be studied in post mortem samples.
Next to oedema formation, an abundant influx of neutrophils
is a characteristic of the lung in sepsis, while this influx is less
pronounced in the kidney. Neutrophil recruitment and diaped-
esis is guided by selectins and cellular adhesion molecules,
which have been extensively studied in mouse sepsis (15). We
studied additional components of the process, i.e., PV-1, CD31,
and endomucin, all located on the EC membrane and involved
in multiple EC-related functions as adhesion molecules, signal-
ing molecules, or both. PV-1 is involved in leukocyte transport,
but has also a role in the repair of glomerular fenestration (28).
This latter role may explain the increased expression of PV-1
expression in mouse kidney at 24 h after LPS administration
and in human septic kidneys. The persistent reduction of PV-1
expression in mouse lungs is not compatible with increased
neutrophil infiltration reported before. Similarly, reduced
expression of CD31 in mouse lungs at 4 and 8 h after LPS
injection is not in line with increased neutrophil infiltration in
this organ, nor is its increased expression in human sepsis
kidneys in line with a moderate renal neutrophil influx.
The sialomucin endomucin binds L-selectin and mediates
leukocyte rolling. Decrease in endomucin expression reduces
rolling and enhances firm leukocyte adhesion (29), a process
preceding diapedesis. In our study, transiently decreased endo-
mucin expression in lung at early time points would support
increased neutrophil infiltration in this organ, while increased
expression at late time points in the kidney would argue for
lower neutrophil infiltration in this organ. Moreover, findings
on endomucin expression in mouse kidney were not compar-
able to those in human sepsis kidney.
Endothelial junctional complexes are regulated by several
signaling systems, among which Ang/Tie and VEGF/VEGF-R
receptor signaling. The Ang/Tie system is involved in vasculo-
genesis, angiogenesis, permeability control, and cell adhesion
(20, 23), often in conjunction with VEGF (24). Ang-1 antagon-
izes VEGF by sequestering intracellular Src, resulting inCopyright © 2017 by the Shock Society. Unauthorizereduced phosphorylation and internalization of VE-cadherin,
and thus decreased permeability (24). In our study, the two
signaling systems displayed an organ-specific expression pat-
tern in untreated mice. After LPS injection, a strong decline in
Ang-1 expression in the lung, together with a decrease in Tie-2
and VE-cadherin protein expression, suggests that the endo-
thelial layer may be destabilized and permeability may
increase. In kidney, Ang-1 expression decreased far less
and recovered more rapidly. Although Tie2 expression also
decreased, it recovered quickly and increased at 24 h after
LPS injection, suggesting that signaling may promote
reduced permeability.
Ang1 and Ang2 are context-dependent antagonists and there-
fore the Ang1/Ang2 ratio is thought to be a determinant for
their net signaling effect on EC (23). A low systemic Ang1/
Ang2 ratio is associated with a higher permeability, decreased
vascular integrity, and with higher mortality in sepsis patients.
In our study, the Ang1/Ang2 ratio was lower in untreated mouse
kidney compared with mouse lung and the Ang1/Ang2 ratio
decreased after LPS exposure, an effect that was more pro-
nounced in the lung than in the kidney. The kinetics of the
Ang1/Ang2 ratio and Tie-2 expression are compatible with
organ-specific permeability differences. Of course we only
measured mRNA and this compatibility supposes a correlation
between mRNA level and protein presence.
The VEGF family is involved in vascular permeability
regulation, via yet incompletely understood mechanisms (7,
13, 30). The effect of VEGF on endothelial cell permeability in
culture is dose dependent (31). In kidney, tight VEGF regula-
tion is required for the development and maintenance of an
intact glomerular filtration function. Studies evaluating renal
VEGF in sepsis are scarce. We showed that after LPS injection,
VEGFA, VEGFR1, and VEGFR2 expression was fairly stable
in the kidney but declined sharply in the lung. These obser-
vations in the lung are in line with reduced pulmonary VEGF
signaling in acute lung injury (32).
Our study has several limitations, among which first and
foremost the fact that the complexity of endothelial per-
meability regulation does not allow more than a reductionist
investigation in mice of a selection of molecules involved in
this process. We studied mRNA but the effect of mRNA levels
on the function, in this case permeability, is regulated by many
post-transcriptional steps and a straightforward relationship
cannot be assumed (19). We use LPS injection in young healthy
mice to elicit some of the responses seen in sepsis. This is an
oversimplification of the clinic where we are confronted with
older patients with comorbidity, comedication, different patho-
gens, genetic polymorphisms, lead-time bias, and treatment
differences. The strengths and weaknesses of research mice
have to be balanced carefully (19). Endothelial cells respond to
LPS via TLR4. We did not study TLR4 expression differences
and can therefore not exclude a nonlinear effect of endothelial
TLR4 signaling. There is a major difference in leukocyte influx
between lung and kidney, this might also cause differences in
adhesion molecule expression. The signaling pathways
involved in the expression differences we found deserve further
study. Functional consequences of the organ-specific, divergent
expression patterns, and as yet unknown underlying regulatingd reproduction of this article is prohibited.
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require a full array of KO and overexpression mouse models.
Moreover, the mouse LPS injection model has limited resem-
blance with the clinical syndrome of sepsis or MODS, even
though expression of 5 of 12 molecules in the late stage of the
mouse LPS model showed similar expression in human sepsis
kidneys versus human control kidneys. Nevertheless, incre-
mental improvements to the current work can be added in future
studies. For example, we expect that laser microdissection of
specific micro-vascular beds prior to gene (array) expression
analysis will provide additional information regarding intra-
organ, microvascular segment-specific endothelial responses
(20, 27), which in the current study have been masked by whole
organ analysis. In fact, this microvessel, segment-specific
approach may give us more insight into the organ-specific
vascular microenvironments, which govern endothelial per-
meability. Regarding human material, efforts to establish a
collection of, e.g., lung and liver tissue from sepsis patients and
healthy donors will greatly facilitate the evaluation of inter-
organ differences in expression patterns of vascular per-
meability governing molecules in human sepsis. In future
studies, we will try to study endothelial behavior in more
organs of patients with multiple organ failure.
While major differences in the expression of adhesion
molecules between organs have been reported before in endo-
toxaemia, caecal ligation and puncture, and animal models of
haemorrhagic shock (33, 34), our study explores organ-specific
responses of molecular controllers of EC permeability. The
involvement of junctional molecules in MODS is supported by
the increase of JAM-1 in plasma of severe trauma patients. In
mice the JAM-1 is decreased in lungs but a response in the
kidney was not studied (18). The observed organ-specific
responses in molecular controllers of EC permeability might
have therapeutic implications. For example, administration of
exogenous Ang-1 or synthetic Ang-1 mimetics in animal
studies led to decreased vascular leakage and survival benefit
(35, 36). Furthermore, inhibition of Rho, which alters VE-
cadherin function, reduces pulmonary oedema (37). Yet, our
finding that expression of molecular controllers of EC per-
meability can strongly differ between organs also illustrates
potential drawbacks of systemic interventions, which may
differentially affect the function of organs such as kidney
and lung.
In conclusion, our study provides insight into the occurrence
of important organ-related differences in micro-vascular per-
meability-associated mRNA of molecules in response to LPS.
Some of the differences seen in mice concur with those found in
human sepsis kidneys. These differences may partly explain the
striking diverging manifestations of organ permeability
observed in patients with multiple organ failure. Manipulation
of vascular permeability might be a target for therapy in
MODS, but our study also emphasizes the challenges that such
a therapy faces, since improving the vascular function of one
organ might endanger the vascular function of another.
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